Adv Ther (2018) 35:857–863 https://doi.org/10.1007/s12325-018-0715-z BRIEF REPORT Comparison of Outcomes of Different Postoperative Hormone Therapy in the Treatment of Ovarian Endometriosis: A Brief Report . . . Songnan Zhu Yingjun Zhu Yabo Liu Hong Zhang Received: March 20, 2018 / Published online: June 5, 2018 Springer Healthcare Ltd., part of Springer Nature 2018 Results: Compared with group A, group B1, B2 ABSTRACT and C showed signiﬁcantly improved menstrual bleeding proﬁles and reduced cumulative Introduction: Hormone therapy is widely used recurrence rate and endometrioma diameter in the treatment of patients with ovarian after recurrence. In addition, compared with endometriosis after surgery, and progestin and group C, menstrual bleeding proﬁles were sig- gonadotropin-releasing hormone (GnRH) are niﬁcantly improved and cumulative recurrence two of the most widely used hormones. This rate and endometrioma diameter were signiﬁ- study aimed to compare the outcomes of pro- cantly reduced in group B1 and B2. No signiﬁ- gestin and GnRH in the treatment of ovarian cant differences in incidence of complications endometriosis after surgery. during treatment were found among groups. Methods: A total of 399 patients with ovarian After treatment, recurrence rate and endometriosis were included and divided into endometrioma diameter were signiﬁcantly four groups to
Advances in Therapy – Springer Journals
Published: Jun 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera